Healthy Subjects Clinical Trial
Official title:
The Effect of Praying on Endogenous Pain Modulation and Pain Intensity in Healthy Religious Individuals: A Randomized Controlled Experiment
Verified date | August 2021 |
Source | Antonine University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
With this study the investigators wish to examine the effect of prayer on pain intensity and on the conditioned pain modulation in healthy religious university students.
Status | Completed |
Enrollment | 208 |
Est. completion date | February 1, 2021 |
Est. primary completion date | February 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 25 Years |
Eligibility | Inclusion Criteria: - Healthy female. - Healthy male. - University students - Religious participants who would score at least two over six on the Non Organizational Religious Activities subscale of the Duke University Religious Index. Exclusion Criteria: - Pregnant women. - Individuals with chronic pain. - Individuals with psychiatric disease. - Individuals suffering from headache for more than 2 days a month. - Individuals with high blood pressure. - Individuals under regular use of medication. - Individuals who would score 1 or 0 on the on the Non Organizational Religious Activities subscale of the Duke University Religious Index. |
Country | Name | City | State |
---|---|---|---|
Lebanon | Antonine University | Beirut |
Lead Sponsor | Collaborator |
---|---|
Antonine University | University Ghent |
Lebanon,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in conditioned pain modulation (CPM) | the conditioned pain modulation paradigm (pressure pain threshold using a digital algometer as test stimulus and the heat pressor test (immersion of one hand in hot water of 45.5°C) as conditioning stimulus | Measured prior to intervention (baseline=day 1) and immediate following the intervention (=day 1) | |
Primary | change in pain intensity | numeric rating scale from 0 to 100 where 0 is no pain and 100 is the worst pain imaginable | Measured prior to intervention (baseline=day 1) and immediate following the intervention (=day 1) | |
Secondary | The Duke University Religion Index | 1.The religiosity level will be measured using the Duke University Religiosity scale, it is a 5-item self-report measure of religious involvement scored on a 5-point Likert-type scale ranging from 1 (almost never) to 5 (a great deal). It assesses the three major dimensions of religiosity, organizational religious activity, non-organizational religious activity, and intrinsic religiosity . | religiosity is assessed at baseline | |
Secondary | Prayer function scale | is a self-report instrument that assesses the motivation or purpose behind an individual's prayer while she or he is coping with difficult circumstances.
The scale consists of 58 items that are scored on a 5-point Likert-type scale ranging from 1 (almost never) to 5 (a great deal). The measure contains four scales: Provides Acceptance (17 items), Provides Calm and Focus (11 items), Deferring/Avoiding , and Provides Assistance (14 items). The deferring/avoiding scale represent a passive type of prayer The assistance scale represent an active type of prayer. |
the prayer function scale is assessed at baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |